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Abstract 
Inflammation is associated with oxidative stress and characterized by elevated levels 
of damage-associated molecular pattern (DAMP) molecules released from injured or even 
living cells into the surrounding microenvironment. One of these endogenous danger signals 
is the extracellular mitochondrial DNA (mtDNA) containing evolutionary conserved 
unmethylated CpG repeats. Increased levels of reactive oxygen species (ROS) generated by 
recruited inflammatory cells modify mtDNA oxidatively resulting primarily in accumulation 
of 8-oxo-7,8-dihydroguanine (8-oxoG) lesions. In this study, we examined the impact of 
native and oxidatively modified mtDNAs on the phenotypic and functional properties of 
plasmacytoid dendritic cells (pDCs), which possess a fundamental role in the regulation of 
inflammation and T cell immunity. Treatment of human primary pDCs with native mtDNA 
up-regulated the expression of a co-stimulatory molecule (CD86), a specific maturation 
marker (CD83), and a main antigen-presenting molecule (HLA-DQ) on the cell surface, as 
well as increased TNF- and IL-8 production from the cells. These effects were more 
apparent when pDCs were exposed to oxidatively modified mtDNA. Neither native nor 
oxidized mtDNA molecules were able to induce interferon (IFN)- secretion from pDCs 
unless they formed a complex with human cathelicidin LL-37, an antimicrobial peptide. 
Interestingly, simultaneous administration of a Toll-like receptor (TLR)9 antagonist abrogated 
the effects of both native and oxidized mtDNAs on human pDCs. In a murine model, oxidized 
mtDNA also proved a more potent activator of pDCs compared to the native form, except for 
induction of IFN- production. Collectively, we demonstrate here for the first time that 
elevated levels of 8-oxoG bases in the extracellular mtDNA induced by oxidative stress 
increase the immunostimulatory capacity of mtDNA on pDCs.  
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Highlights 
We compared the immunostimulatory capacity of native and oxidized mtDNA on 
pDCs.8-Oxoguanin-containing mtDNA has a greater capacity to activate primary human 
pDCs. 
In vivo, oxidized mtDNA also proved a more potent activator of pDC than native mtDNA. 
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Introduction 
Mitochondria have crucial role in many cellular processes, including ATP, fatty acid 
and steroid hormone synthesis, the maintenance of Ca2+ homeostasis, thermogenesis and 
generation of reactive oxygen species (ROS). Furthermore, mitochondria are heavily 
integrated into pathways of cell death signaling, innate immunity and autophagy (reviewed in 
[1]). It is generally accepted that mitochondria are descended from a specialized, free-living, 
prokaryotic cell that survived endocytosis by another species of prokaryotes. In accordance 
with their prokaryotic origin, mitochondria still possess several morphological and 
biochemical characteristics of their bacterial ancestor, including a circular DNA genome 
containing unmethylated CpG oligodeoxynucleotide (ODN) sequences (reviewed in [2]). 
Therefore, mitochondrial DNA (mtDNA) molecules released by injured [3] or even living 
cells [4] are sensed as danger signals eliciting immunological responses (reviewed in [5]). 
Unmethylated CpG motifs in bacterial DNA [6], as well as in circulating mtDNA are 
recognized by Toll-like receptor 9 (TLR9) [7] expressed by various cells of the innate 
immune system [8, 9]. Among the leukocytes, human plasmacytoid dendritic cells (pDCs) are 
considered to be specialized for the recognition of nucleic acids of invading microbes, 
because in conjunction with TLR9 they also express single-stranded RNA-sensing TLR7 [10, 
11]. Ligation of these endosomal TLRs initiates the secretion of various inflammatory 
cytokines and the production of large amounts of type I interferons (IFNs), which possess 
strong antiviral and immunomodulatory properties [12]. Because of their constitutively high 
level of TLR9 expression [13], human pDCs may serve as a primary sensor for mtDNA. 
Indeed, it has been previously reported that mtDNA fragments induce maturation, migration 
and type I IFN production of pDCs [14]. However, this former work has focused on the 
immunostimulatory properties of CpG islands and CpG-containing ODN derived from 
mtDNA [14]. In our study, we considered the pDC-activating potential of extracellular 
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mtDNA from another possible aspect, which has not been investigated yet. 
Several lines of evidence indicate that pathogen-induced and even sterile 
inflammations are associated with oxidative stress generated by inflammatory cells recruited 
to the infected or injured tissues [15, 16]. This oxidative extracellular milieu and elevated 
levels of intracellular ROS are able to cause oxidative modification of mtDNA either before 
or after its release. The primary target of ROS in DNA is guanine due to its lowest redox 
potential among DNA bases, so 8-oxo-7,8-dihydroguanine (8-oxoG) is one of the most 
abundant base lesions [17, 18]. In mammals, the intra-helical 8-oxoG is recognized and 
excised by the E. coli Fpg homolog 8-oxoguanine DNA glycosylase 1 (OGG1) from nuclear 
and mitochondrial genome during base excision repair processes [19, 20]. The resulting free 
8-oxoG base is capable of binding to OGG1 with high affinity, and the complex then 
functions as an activator of Ras and Rho family GTPases contributing to oxidative stress 
related cellular responses [21-23]. Here, our aim was to investigate the consequence if 8-oxoG 
is not removed from mtDNA and the oxidatively modified mtDNA is released from the cells. 
We hypothesized that accumulation of 8-oxoG during inflammation enhances the 
immunostimulatory capacity of mtDNA, and the 8-oxoG-enriched mtDNA has a greater 
potential to activate pDCs infiltrated into the inflamed tissues. To test this hypothesis we 
compared the phenotypic and functional properties of pDCs upon exposure to native or 
oxidatively modified mtDNA under in vitro as well as in vivo conditions. 
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Materials and methods 
 
Cell cultures 
 
Human promyelocytic leukemia HL-60 cells (American Type Culture Collection, 
CCL-240) and murine SP2/0-Ag14 cells (American Type Culture Collection, CRL-1581) 
were routinely grown in RPMI 1640 medium (Sigma-Aldrich, St. Louis, MO, USA) 
supplemented with 2 mM L-glutamine (Sigma-Aldrich), 100 U/ml penicillin, 100 ng/ml 
streptomycin and 10% heat-inactivated FBS (Life Technologies Corporation, Carlsbad, CA, 
USA). Both cell types were cultured at 37 ºC in 5% CO2 humidified atmosphere. 
 
Generation and detection of mitochondrial oxidative stress 
 
Human HL-60 cells or murine SP2/0-Ag14 cells were loaded with 5 µM MitoSoxTM 
Red probe (Life Technologies Corporation) and incubated for 10 min at 37 ºC protected from 
light. After that cells were washed gently three times with warm PBS buffer (Sigma-Aldrich) 
to remove the excess fluorescent dye and were cultured at a density of 5x106 cells/ml in RPMI 
1640 medium (Sigma-Aldrich) supplemented with the above mentioned components. The 
MitoSoxTM Red loaded cells were exposed to increasing concentration of antimycin A (50 
µg/ml, 100 µg/ml, 200 µg/ml; Sigma-Aldrich) for 2 h. The changes in MitoSoxTM Red 
fluorescence intensity were measured at 580 nm using a BD FACS Calibur flow cytometer 
(Becton Dickinson, Franklin Lakes, NJ, USA) and data were analyzed by FlowJo software 
(Treestar, Ashland, OR, USA). In parallel experiments the viability of the antimycin A-
exposed cells were determined by 7-aminoactinomycin-D (7-AAD; 10 µg/ml; Sigma-Aldrich) 
staining using flow cytometric analysis. 
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Isolation of mitochondrial DNA 
 
The mtDNA was extracted from untreated and antimycin A-treated human HL-60 
cells and murine SP2/0-Ag14 cells using Biovision Mitochondrial DNA Isolation Kit 
(Gentaur Belgium BVBA, Kampenhout, Belgium), according to the manufacturer’s 
instructions. Briefly, a total of 5x107 cells were collected by centrifugation at 600 g for 5 min 
at 4 C° and washed with ice-cold PBS. After centrifugation (600 g, 5 min, 4 C°) cells were 
resuspended in cytosol extraction buffer and incubated on ice for 10 min. Then the cells were 
homogenized with ice-cold Dounce tissue grinder. The homogenate was centrifuged at 700 g 
for 10 min at 4 C° to remove nuclei and intact cells. Mitochondria were pelleted from the 
supernatant by centrifugation at 10000 g for 30 min at 4 C°. This centrifugation step was 
repeated after resuspending the pellet in fresh ice-cold cytosol extraction buffer. After that 
isolated mitochondria were lysed, and mtDNA was purified using standard ethanol 
precipitation. Namely, the enzyme-lysed mitochondria were mixed with absolute ethanol and 
kept at -20 C° for 10 min. The precipitated mtDNA was centrifuged at 16000 g for 5 min at 
room temperature and the pellet was washed 2 times with 70 % ethanol. After removing the 
trace amount ethanol mtDNA was air dried (5 min) and dissolved in TE buffer (Life 
Technologies Corporation). The concentration and purity of isolated mtDNA were determined 
by NanoDrop spectrophotometer (Thermo Scientific, Rockford, IL, USA). In case of every 
mtDNA sample the A260/280 ratio was between 1.8 and 1.9. To test the possibility of 
contamination of the mtDNA samples with nuclear DNA, the NovaQUANT Human 
Mitochondrial to Nuclear DNA Ratio Kit (MerkMillipore, Darmstadt, Germany) was used 
according to the manufacturer’s recommendations. The mtDNA samples were probed for two 
mitochondrial genes (ND1, ND6) and for two nuclear DNA marker genes (BECN1, NEB) 
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using the ABI StepOne Real Time PCR System (Life Technologies Corporation). It was found 
that in contrast to the mitochondrial genes, none of the tested nuclear DNA genes could be 
detected in the mtDNA samples. The integrity of mtDNA molecules prepared from untreated 
and antimycin A-treated cells was analyzed by a standard agarose gel electrophoresis. 
Mitochondrial DNAs were run on 0.8 % agarose gel and then visualized by SYBR Green I 
fluorescent intercalating dye under ultraviolet light. 
 
Detection of 8-oxoG in the isolated mtDNA samples using dot blot analysis 
 
To determine the 8-oxoG content of mtDNA extracted from untreated and antimycin 
A-treated cells, 1 µg of mtDNA was spotted onto a nitrocellulose membrane. After drying the 
non-specific binding was blocked in TBS-T buffer (50 mM Tris, 0.5 M NaCl, 0.05% Tween-
20, pH 7.4) containing 5% dry milk for 1 h at room temperature. Following the blocking step 
the membrane was incubated with mouse anti-8-oxoguanine monoclonal antibody (1:1000, 
clone 483.15, MerkMillipore) in TBS-T buffer containing 5% dry milk for 1 h at room 
temperature. After incubation the membrane was washed three times with TBS-T buffer and 
anti-mouse IgG conjugated with HRP (GE Healthcare, Little Chalfont, Buckinghamshire, 
UK) was used as a secondary antibody at a dilution of 1:10000. After 1 h incubation and 
repeated wash steps blot results were visualized by ECL system (SuperSignal West Femto 
Chemiluminescent Substrate; Thermo Scientific). Spot signals were quantified using the 
image analysis software Kodak 1D 3.6 (Eastman Kodak Company, Rochester, NY, USA). 
After detection of 8-oxoG in the mtDNA samples, the same membrane was washed 
thoroughly with distilled deionized water and stained with ethidium bromide (Sigma-Aldrich) 
dissolved in 1X TAE (Tris-acetate-EDTA) buffer for 30 min at room temperature. After 
rinsing the membrane with 1X TAE buffer, ethidium bromide binding was visualized and 
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photographed under UV light in Alpha Imager HP System (ProteinSimple, CA, USA). 
 
Isolation of primary human pDCs  
 
Peripheral blood mononuclear cells (PBMC) were isolated from heparinized 
leukocyte-enriched buffy coats by standard Ficoll-Paque (GE Healthcare) density gradient 
centrifugation. Untouched human pDCs were purified from PBMC by negative selection 
using immunomagnetic cell separation kit (Miltenyi Biotec, Bergish Gladbach, Germany), 
according to the manufacturer’s instruction. After separation on VarioMACS magnet, the 
purity of BDCA2+ BDCA4+ CD123+ pDCs was >98% as confirmed by flow cytometry. 
Human buffy coats were obtained from healthy blood donors drawn at the Regional 
Blood Center of Hungarian National Blood Transfusion Service (Debrecen, Hungary) in 
accordance with the written approval of the Director of the National Blood Transfusion 
Service and the Regional and Institutional Ethics Committee of the University of Debrecen, 
Medical and Health Science Centre (Debrecen, Hungary).  
 
In vitro stimulation of primary human pDC  
 
Freshly isolated primary human pDCs were seeded at 1x105 cells/well in 96-well flat-
bottom plates in RPMI 1640 medium (Sigma-Aldrich) supplemented with 2 mM L-glutamine 
(Sigma-Aldrich), 100 U/ml penicillin, 100 ng/ml streptomycin, 10% heat-inactivated FBS 
(Life Technologies Corporation) and 50 ng/ml recombinant human IL-3 (PeproTech, London, 
UK). For stimulation, pDCs were exposed for 24 h to 7 µg of mtDNA prepared from 
untreated and antimycin A-treated human HL-60 cells. An optimal concentration of mtDNA 
for cell activation was determined in preliminary experiments. In control experiments, pDCs 
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were pre-incubated for 1 h with TLR9 inhibitory ODN TTAGGG oligonucleotide (InvivoGen, 
San Diego, CA, USA) and then co-treated with 7 µg of mtDNAs for 24 h (mtDNA: inhibitory 
ODN ratio, 1:5). For the induction of human pDCs’ type I IFN secretion, 35 µg of LL-37 
protein (Sigma-Aldrich) were premixed with 7g of mtDNA (peptide: mtDNA mass ratio of 
5:1) in sterile PBS (PAA Laboratories GmbH) for 30 min at room temperature. After 
incubation the mix was added to the primary pDC cultures (final concentration was 175 
g/ml of LL-37 and 35 g/ml of mtDNA). The treated cells were incubated at 37 ºC in 5% 
CO2 humidified atmosphere for 24 h and then supernatants were collected and stored at -70 ºC 
until cytokine measurements. 
 
Phenotypic analysis of primary human pDCs by flow cytometry 
 
Cell surface protein expression was analyzed by staining the cells with PE-labeled 
human monoclonal antibodies against CD86 (R&D System, Minneapolis, MN, USA), HLA-
DQ (BioLegend, San Diego, CA, USA) and PE-Cy5-labeled anti-CD83 (BD Pharmingen, San 
Diego, CA, USA) monoclonal antibodies. Isotype-matched control antibodies were obtained 
from BD Pharmingen. Fluorescence intensities were measured by FACSCalibur flow 
cytometer (BD Biosciences Immunocytometry Systems) and data analysis was performed by 
FlowJo software (TreeStar). 
 
Measurement of cytokine and chemokine secretion of primary human pDCs 
 
ELISA kits (BD OptEIA; BD Biosciences, San Diego, CA, USA) were used to 
quantify IL-8 chemokine, as well as TNF- cytokine. Human IFN-α ELISA kit (with a 
detection limit of 12.5 pg/ml) was purchased from PBL InterferonSource (Piscataway, NJ, 
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USA). Assays were performed according to the manufacturer’s instructions. Absorbance 
measurements were performed with a Synergy HT micro plate reader (Bio-Tek Instruments, 
Winooski, VT, USA) at 450 nm. 
 
In vivo mice experiments 
 
For in vivo treatments, 6- to 8-week-old 129Sv female mice (The Jackson Laboratory, 
Bar Harbor, ME, USA) were injected with 200 µl of sterile PBS (Sigma-Aldrich) as a control 
or 200 µl of mtDNA preparations i.v. into the lateral tail vein. The preparations contained 10 
µg of mtDNA isolated from untreated or from antimycin A-treated murine SP2/0-Ag14 cells 
mixed with 30 µl of cationic liposomal transfection reagent (DOTAP; Sigma-Aldrich) 
dissolved in sterile PBS (Sigma-Aldrich). Mice were sacrificed and blood was collected by 
cardiac puncture at 6 h after treatments. For analysis of in vivo cytokine and chemokine 
production, sera were collected from whole blood by centrifugation at 3500 g for 5 min at 
room temperature and tested for IFN-, TNF-, IL-6 and CXCL1/KC proteins using mouse 
specific ELISA kits (mouse IFN- ELISA kit [with a detection limit of 50 pg/ml] from TSZ 
Scientific LLC., and mouse TNF-, IL-6, CXCL1/KC ELISA kits from R&D Systems). 
Blood cells were stained with FITC-conjugated anti-CD86, PE-conjugated I-A/I-E (both from 
BioLegend), APC-conjugated mPDCA-1 (Miltenyi Biotec) mouse antigen specific 
monoclonal antibodies and the respective isotype controls from the same sources for 20 min 
in the dark and resuspended in 1x BD FACSTM Lysing Solution (BD Bioscience, San Jose, 
CA, USA) for 30 min at room temperature to remove red blood cells. Following repeated 
wash steps with PBS (Sigma-Aldrich), the phenotypic changes of the mouse cells were 
determined by flow cytometric analysis. The mouse pDC population was identified by the 
mouse specific pDC marker, mPDCA-1, and the phenotypic analysis was performed on the 
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gated mPDCA-1+ pDC population.  
Care and handling of animals followed the Helsinki Declaration, European Union 
regulations and adhered to the guidelines of the Committee for Research and Ethical Issues of 
IASP. All animal study protocols were approved by the Animal Care and Protection 
Committee at the University of Debrecen (#7/2011/DE MAB). Animals were maintained in 
the pathogen-free animal facility of the University of Debrecen. 
 
Statistical analysis 
 
Data from the different treatment groups were analyzed by Student’s paired t test or 
ANOVA, followed by Bonferroni post hoc analyses for least-significant differences. Data 
analysis was performed with GraphPad Prism v.6. software (GraphPad Software Inc., La 
Jolla, CA, USA). Differences were considered to be statistically significant at P < 0.05. 
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Results 
 
Inhibition of mitochondrial electron transport chain at complex III results in elevated 8-oxoG 
levels in mtDNA 
 
Antimycin A, a well-known specific inhibitor of mitochondrial electron transport 
chain at complex III [24], was applied to induce oxidative modification of mtDNA in both 
human HL-60 and murine SP2/0-Ag14 cells. To determine the optimal amount for generation 
of mtDNA damage, cells were treated with increasing concentrations of antimycin A for 2 h. 
Mitochondrial ROS production was assessed using MitoSoxTM Red, a mitochondrial 
superoxide indicator, while cellular viability was determined by 7-AAD staining. Exposure of 
either human or murine cells to 100 µg/ml of antimycin A resulted in a significant increase in 
the MitoSoxTM Red fluorescence without significant cellular toxicity (Suppl. Fig. 1). Higher 
concentration of antimycin A (200 µg/ml) did not cause further increase in MitoSoxTM Red 
fluorescence intensity but triggered a 30% drop in cell viability (Suppl. Fig. 1). Based on 
these observations, for in vitro and in vivo pDC stimulations, native mtDNA was extracted 
from untreated human and murine cells, whereas oxidatively modified mtDNA was isolated 
from cells exposed to 100 µg/ml of antimycin A. 
To test whether antimycin A treatment of the cells led to oxidative modification of 
their mtDNA, 8-oxoG levels correlating with the oxidized state of the nucleic acid [17, 18] 
were investigated in the purified mtDNA samples by dot blot method. We found that the 
amount of 8-oxoG in the mtDNA from antimycin A-treated human HL-60 cells were ~5 times 
higher than in mtDNA from untreated cells (Fig. 1A). A similar increase in 8-oxoG levels was 
observed in the mtDNA samples extracted from the antimycin A-treated murine SP2/0-Ag14 
cells (Fig. 1B). 
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In addition to induction of base lesions, oxidative stress may also cause strand breaks 
resulting in DNA fragmentation. To compare the integrity of native and oxidatively modified 
mtDNA molecules after extraction, mtDNA samples were electrophoresed on a standard 
agarose gel and stained with SYBR Green I intercalating fluorescent dye. The electrophoretic 
mobility of the native and oxidized mtDNA isolated from either the HL-60 or the SP2/0-Ag14 
cells was identical, suggesting that antimycin A-treatment does not cause detectable mtDNA 
fragmentation (Suppl. Fig. 2). 
 
Mitochondrial DNA with higher 8-oxoG content has a greater capacity to induce phenotypic 
changes on primary human pDCs 
 
To investigate the possible differences in the immunostimulatory properties of the two 
forms of mtDNAs, freshly isolated primary human pDCs were exposed to native or 
oxidatively modified mtDNA extracted from human HL-60 cells. Expression of a co-
stimulatory molecule (CD86), a specific maturation marker (CD83), and a main antigen-
presenting molecule (HLA-DQ) on pDCs was evaluated by means of flow cytometry. 
Treatment of pDCs with native mtDNA resulted in a significant increase in the expression of 
CD86 (Fig. 2A) and CD83 (Fig. 2C), while it markedly, but not significantly enhanced the 
HLA-DQ levels (Fig. 2B) on the cell surface. When cells were exposed to high 8-oxoG-
containing mtDNA, a further increase in the expression of all tested molecules was detected 
indicating that the oxidatively modified mtDNA has a greater potential to induce phenotypic 
changes on pDCs (Fig. 2A-C). 
Previous studies have provided evidence that TLR9 is a specific receptor for microbial 
DNA [9], therefore we supposed that the effects of mtDNA containing CpG motifs on human 
pDCs are mediated via TLR9 selectively expressed in these cells. To test this hypothesis, 
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mtDNA treatments were repeated in the presence of TTAGGG ODN, a specific competitive 
inhibitor of TLR9. The results showed that pre-treatment of the cells with the TLR9 
antagonist, prevented the above described phenotypic changes on pDCs, independently from 
the state of oxidation of mtDNAs (Fig. 2A-C). These observations strongly suggest that the 
phenotypic maturation of pDCs induced by native as well as oxidized mtDNA treatments was 
mainly mediated through TLR9. 
 
Cytokine and chemokine production of primary human pDCs is potentiated by the presence of 
high level of 8-oxoG in mtDNA 
 
To further examine the effects of high 8-oxoG content of mtDNA on pDC functions, 
freshly isolated pDCs were treated with native and oxidized mtDNA purified from non-treated 
or oxidative stress-exposed human HL-60 cells, respectively. Levels of TNF- and IL-8 were 
determined in the supernatants of the cell cultures by means of ELISA. The administration of 
native mtDNA augmented the secretion of both TNF- (Fig. 3A) and IL-8 (Fig. 3B); however, 
it induced statistically significant increase only in the case of the former one (Fig. 3A). 
Compared to the treatment with native mtDNA, the stimulation of primary pDCs with the 
oxidized form of mtDNA resulted in an enhanced production of both mediators (Fig. 3A and 
B). The observed increase in the release of IL-8 was more conspicuous than that of TNF- 
(Fig. 3A and B). Similarly to the phenomenon observed in the phenotypic analyses, the 
presence of a TLR9 antagonist prevented the enhanced TNF- and IL-8 production from 
pDCs induced by either native or oxidatively modified mtDNA (Fig. 3A and B) suggesting 
that the activation of pDCs was initiated by TLR9-dependent recognition of mtDNAs.  
 
Neither native nor oxidatively modified mtDNA alone is able to induce IFN- secretion of 
 16 
primary human pDCs 
 
As pDCs are considered to be professional type I IFN-producing cells [25], the effect 
of the mtDNA treatments on IFN- secretion was also investigated. The concentration of IFN-
 was measured in the supernatants of the native and oxidized mtDNA-exposed primary 
human pDCs by means of ELISA. We found that administration of neither native nor 
oxidatively modified mtDNA induced IFN- secretion of the cells (Fig. 4). Previous studies 
have reported that nuclear DNA alone is not able to trigger the production of IFN- by human 
pDCs, while nuclear DNA pre-incubated with human cathelicidin (LL-37), an antimicrobial 
peptide, is capable of doing so [26]. Based on this previous finding, mtDNA samples were 
pre-incubated with LL-37 before addition to the cell cultures. In complex with LL-37, both 
native and oxidized forms of mtDNA were able to provoke IFN- production by pDCs (Fig. 
4). It is worth noting that the native form resulted in significantly more IFN- release than the 
oxidatively modified form. Furthermore, simultaneous administration of a TLR9 antagonist 
totally inhibited the secretion of this mediator induced by both kinds of mtDNA (Fig. 4). 
 
Oxidized mtDNA is a more potent in vivo activator of pDCs than its native form 
 
To test the hypothesis that oxidatively modified mtDNA is a more potent activator of 
pDCs in vivo than the native form, mtDNA was extracted from either untreated or antimycin 
A-treated murine SP2/0-Ag14 cells and intravenously injected into 129Sv mice. It has been 
previously reported that estrogens enhance pDCs’ immune responses after TLR-7/TLR-9 
stimulation in mice [27]. In order to get a more powerful and easily detectable immune 
activation after administration of mtDNA, only female animals were included in our study. 
Peripheral blood samples were collected after 6 h incubation and multi-color flow cytometric 
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analysis was performed to identify mouse pDCs and assess their phenotypic changes. In vivo 
treatment with native mtDNA induced an increase in the expression levels of both CD86 co-
stimulatory (Fig. 5A) and I-A/I-E antigen-presenting molecules (Fig. 5B) on mouse pDCs; 
however, the changes were found to be statistically significant in the latter case only. 
Administration of oxidized mtDNA triggered a significantly stronger increase in the 
expression of both investigated cell surface molecules than that of the native form (Fig. 5A 
and B).  
To compare the in vivo effects of the two forms of mtDNA on cytokine and chemokine 
levels, serum samples of 129Sv mice injected with native and 8-oxoG-enriched mtDNAs 
isolated from untreated and antimycin A-treated murine SP2/0-Ag14 cells were analyzed for 
IL-6, TNF- and CXCL1/KC by means of ELISA. In sera of mice injected with oxidized 
mtDNA, statistically significant increases in the levels of IL-6 (Fig. 6A), TNF- (Fig. 6B) and 
CXCL1/KC (Fig. 6C) were detected. On the contrary, in the sera of native mtDNA-injected 
mice, insignificant elevations could be observed in the levels of all these inflammatory 
mediators (Fig. 6A-C).  
To evaluate the ability of the two distinct forms of mtDNA to induce type I IFN 
secretion in vivo, the amount of IFN- in the serum samples was also measured. Both forms 
of mtDNA significantly enhanced its production; however, exposure of mice to oxidatively 
modified mtDNA led to a less induction of IFN- (Fig. 6D), similarly to our in vitro findings 
with human pDCs (Fig. 4). 
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Discussion 
Plasma level of mtDNA is elevated during severe sepsis and traumatic injury; 
moreover, it is associated with injury severity and predicts the risk of post-traumatic systemic 
inflammatory response syndrome [28, 29]. Mitochondrial DNA has been also detected in 
synovial fluids of patients with rheumatoid arthritis [30]. In addition, a recent study showed 
that regardless of disease activity, circulating mtDNA levels distinguish patients with systemic 
lupus erythematosus from non-inflammatory controls with high sensitivity [31]. Furthermore, 
circulating mtDNA can activate human neutrophils through TLR9, leading to their migration 
and degranulation [3]. These data indicate that extracellular mtDNA acting as a DAMP can 
contribute to innate immune responses. As mtDNA can be released from various cell types 
during infections or under inflammatory conditions closely associated with oxidative stress 
[32, 33], in this work we examined the immunostimulatory properties of oxidatively damaged 
mtDNA on pDCs, which exert a crucial role in the regulation of inflammation and T cell 
immunity [34]. 
Mitochondrial DNA is more vulnerable to oxidative damage than nuclear DNA for 
several reasons. Mitochondria are the primary sites of ROS production within the cells, and 
mtDNA is partially associated with the inner mitochondrial membrane in close proximity to 
the electron transport chain [35, 36]. Furthermore, mtDNA is not protected by histones and 
mitochondrial DNA repair is thought to be less efficient than nuclear DNA repair [35]. As a 
result of these facts, the steady state levels of oxidized bases in mtDNA are several times 
higher than in nuclear DNA [37]. Among the oxidative-damage DNA lesions, 8-oxoG is the 
most prevalent product of the oxidative attack on DNA. It accumulates in mtDNA with age 
and in patients suffering from certain types of cancer or neurodegenerative diseases associated 
with chronic inflammation (reviewed in [38]). This base damage has particular biological 
relevance because, unless repaired, it induces G:C to T:A transversion mutations with high 
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frequencies [39]. Mitochondria contain enzymes whose function is to remove these lesions, 
thus reversing the effects of oxidative insult and preventing mutations [40, 41]. However, 
when oxidative damage to DNA is excessive and mtDNA is released before repair, e.g., under 
inflammatory processes, it may contain high level of 8-oxoG [42]. In this study we 
investigated the immunomodulating potential of this 8-oxoG-enriched mtDNA on both human 
and murine pDCs. 
To mimic oxidative stress conditions we treated the cells with antimycin A, which 
binds to cytochrome b and inhibits electron flow from semiquinone to ubiquinone, 
consequently increasing the steady state concentration of semiquinone and resulting in 
electron escape from complex III [43, 44]. This impairment of the electron transport system 
can increase mitochondrial ROS generation leading to oxidative damage of mtDNA [45]. In 
good agreement with these previous findings, we detected several times higher levels of 8-
oxoG in mtDNA isolated from antimycin A-exposed cells than those from untreated cells. 
Repair of mitochondrial oxidative DNA lesions occurs predominantly through the base 
excision repair pathway [19]. Excision of 8-oxoG is initiated by OGG1, which recognizes and 
removes the base in a free form by cleavage of the glycosylic bond between the damaged base 
and the deoxyribose residue. The resulting abasic site is cleaved by AP endonuclease-1 to 
generate a gap that is filled by DNA polymerase followed by action of DNA ligase to 
complete the repair process [19, 46]. Agarose gel analysis of the mtDNA samples indicated 
that the isolation procedure resulted in partial fragmentation of mtDNA, whereas antimycin 
A-treatment did not result in further detectable changes in mtDNA integrity, despite the fact 
that during repair of 8-oxoG in DNA transient single strand breaks are generated [47]. 
In a recent study it was found that full-length mtDNA possessed immunostimulatory 
activity only if it was transfected into the pDCs using the cationic reagent DOTAP [14]. In 
that study, however, the authors investigated exclusively the IFN- production of mtDNA-
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exposed pDCs. Our study confirms this previous observation and extends it in several ways. 
First, we have also shown here that neither native nor oxidatively modified mtDNA alone was 
able to induce IFN- secretion of human pDCs. However, when mtDNA molecules were pre-
incubated with human cathelicidin (LL-37), an antimibrobial peptide, prior administration to 
the cells, both the native and the oxidized forms induced IFN- production by pDCs. Besides 
its antimicrobial properties, LL-37 contributes to the uptake of extracellular DNA by various 
cell types binding the DNA by virtue of its opposite charges. As previously reported, LL-37 
can convert inert self nuclear DNA into a potent inducer of IFN- production from pDCs by 
protecting extracellular DNA from degradation and forming aggregated and condensed 
complexes with DNA that are delivered to and retained within early endocytic compartments 
to trigger TLR9 [26]. Furthermore, binding of LL-37 to CpG-rich bacterial DNA significantly 
reduces the time required for pDCs and B cells to sense the presence of bacterial DNA via 
TLR [48]. In addition, LL-37 also has the ability to efficiently transport self-DNA into 
cytosolic compartments of monocytes, leading to activation of the cells in a TLR-independent 
manner [49]. Our results demonstrating that a specific competitive inhibitor of TLR9 almost 
completely abolished the ability of mtDNA to induce phenotypic and functional changes on 
pDCs confirm previous observations that mtDNA containing multiple CpG motifs binds and 
activates TLR9 in human pDCs [14]. Previous findings indicate that single-stranded 
mitochondrial ODN molecules are immunostimulatory on pDCs only after DOTAP 
transfection, whereas double-stranded mitochondrial ODN is able to induce pDCs’ maturation 
[14]. Our observations that exposure to mtDNA samples containing full-length mtDNA and 
mtDNA fragments with various lengths can elicit activation of pDCs without transfection are 
in line with these earlier results, and support that human pDCs are able to engulf DNA 
molecules specifically those with higher-order structures. It has recently been reported that 
mtDNA remained in association with the mitochondrial transcription factor A (TFAM) upon 
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release from necrotic cells [50]. TFAM and mtDNA interact with receptors for advanced 
glycation end-products and TLR9, respectively, to promote activation of pDCs [50]. In our 
experiments, we isolated mtDNA from cultured human and murine cells for further 
investigation and in every mtDNA sample the A260/280 ratio was between 1.8 and 1.9, 
excluding a significant protein contamination. Therefore, contribution of TFAM proteins to 
the observed immunostimulatory effects of mtDNA on pDCs in our experimental system 
seems very unlikely. 
Our results from both in vitro and in vivo experiments indicate that the oxidatively 
modified extracellular mtDNA possesses a greater potential to activate pDCs than native 
mtDNA. In line with our observations, in a prior study, purified mtDNA and even an ODN 
that lacked CpG motifs but contained a single 8-oxoG residue induced arthritis when injected 
intra-articularly in mice [30]. In contrast, an ODN with exactly the same sequence, except that 
it lacked the oxidized base, was totally inert in vivo [30]. In another study, CpG ODN 
molecules, in which a guanine base was substituted with 8-oxoG, induced a significantly 
higher amount of TNF- from RAW264.7 macrophage-like cells than control unsubstituted 
ones [51]. The 8-oxoG-containing DNA-induced increase in TNF- production was also 
observed in primary cultured macrophages isolated from wild-type mice, but not observed in 
those from TLR9 knockout mice [51]. In addition, subcutaneous injection of 8-oxoG-
containing CpG ODN led to an increase in footpad swelling compared to that of regular CpG 
ODN [51].  
In our in vivo experiments the phenotypic properties of murine pDCs in peripheral 
blood were investigated by means of flow cytometry, whereas cytokine and chemokine levels 
in the serum samples were measured by ELISA. It is important to note that while flow 
cytometric analysis provides unambiguous data about the pDCs’ phenotypic changes, the 
detected cytokines and chemokine could be released by diverse cell types responding to 
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mtDNA treatment. In humans, TLR9 expression in mononuclear blood cells and lymphoid 
tissues is restricted to B cells and pDCs, whereas in mice, TLR9 expression has also been 
demonstrated in macrophages, myeloid DCs, and activated T cells in addition to pDCs and B 
cells [52]. Despite this fact, the results of our in vivo experiments correlate very well with 
those of cell culture assays. Both in human pDC cultures and mice, treatment with oxidized 
mtDNA resulted in much higher production of all tested mediators, except IFN-, than 
stimulation with the native form. The native form of mtDNA proved to be a better inductor of 
IFN- release. Based on these observations, it seems that effects of oxidized mtDNA on 
TLR9-expressing cells are similar to those of type B CpG ODNs. It has been previously 
shown that type B CpG ODNs predominantly activate pDCs in a manner that results in 
phenotypic changes and pro-inflammatory cytokine production, as well as weak induction of 
type I IFN responses [53]. The functional activity of type B CpG ODNs is attributed to their 
localization to lysosome-associated membrane protein 1-positive endosomes, while activation 
of TLR9 by type A CpG ODNs occurs in transferrin receptor-positive endosomes [54]. 
Although, prior X-ray crystal and NMR structures had showed that DNA with 8-oxoG lesions 
appears virtually identical to the corresponding unmodified duplex, recent thermodynamic 
studies have indicated that 8-oxoG has a destabilizing influence [55]. The presence of 8-oxoG 
has a profound effect on the level and nature of DNA hydration indicating that the 
environment around an 8-oxoG:C is fundamentally different than that found at G:C [55]. The 
instability of the 8-oxoG modification is attributed to changes in the hydrophilicity of the base 
and may influence the recognition of oxidized mtDNA by TLR9. 
While increased levels of extracellular mtDNA were detected during several 
pathological conditions such as chronic inflammations [30], trauma [3], neurodevelopmental 
disorders [56], or different infections [57], the clinical relevance of elevated 8-oxoG levels in 
released mtDNA has not yet been investigated. In a prior study extracellular mtDNA and 
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oxidized DNA (8-oxo-7,8-dihydro-2'-deoxyguanosine, 8-oxodG) were detected in the 
synovial fluid samples of the great majority of patients with rheumatoid arthritis, but were 
absent or present at low levels in the samples of healthy controls [42]. Furthermore, a 
significant correlation was observed between the levels of 8-oxodG and rheumatoid factor 
positivity. Higher concentrations of 8-oxodG (>1.5 ng/ml) in the synovial fluid were also 
associated with more severe clinical manifestations, but the correlations were found not to be 
statistically significant [42]. It is worth mentioning that source of the elevated oxidatively 
damaged DNA adducts (mitochondrial DNA or nuclear DNA) was not identified in that 
study. Although further studies are needed to reveal the clinical significance of our 
observations, our data indicate that a positive correlation between the 8-oxoG level in 
extracellular mtDNA and the severity of clinical symptoms may exist in those diseases in 
which activation of pDCs and/or other TLR-9-expressing cells has pivotal role in the 
pathogenesis. 
In conclusion, we have demonstrated that the oxidatively modified, extracellular 
mtDNA has a greater potential to activate human pDCs and to initiate innate immune 
responses in experimental animals. Our results suggest that oxidized mtDNA originated from 
stressed, damaged or even dying cells during inflammation exacerbates acute and chronic 
immune processes by eliciting the production of chemokines and pro-inflammatory cytokines 
from TLR9-expressing cells. 
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Figure Legends 
 
Figure 1. Detection of 8-oxoG contents of the isolated mtDNAs. Oxidatively modified 
mtDNA was purified from antimycin A-exposed human HL-60 (A) or murine Sp2/0-14Ag (B) 
cells. Native mtDNA was extracted from untreated cells and used as controls. Levels of 8-
oxoG in the isolated mtDNA samples were determined by means of dot blot method. 
Diagrams display the intensities of 12 dots from three independent experiments and results are 
presented as means ± SE. The lower panels show representative dot blots of four parallel 
samples of oxidized and native mtDNA isolated from the indicated cell lines and same blots 
stained with ethidium bromide as DNA loading controls. **** p<0.0001 vs. mtDNA from 
untreated cells. Ox-mtDNA: oxidatively modified mtDNA. 
 
Figure 2. Phenotypic analysis of primary human pDCs treated with native or oxidatively 
modified mtDNA. Freshly isolated primary human pDCs were exposed to native or 
oxidatively modified mtDNA extracted from untreated or antimycin A-exposed HL-60 cells. 
In parallel experiments pDCs were pre-incubated for 1 h with specific TLR9 antagonist 
(TTAGGG) and then treated with native or oxidized mtDNA. Following a 24-h activation, 
expression of CD86 (A), HLA-DQ (B) and CD83 (C) was determined by flow cytometry. 
Relative fluorescence was calculated using the respective isotype-matched control for each 
monoclonal antibody. Data are presented as means ± SE of three independent experiments. ** 
p<0.01, **** p<0.0001 vs. untreated cells; ## p<0.01, #### p<0.0001 vs. mtDNA- or ox-
mtDNA-treated cells. Ox-mtDNA: oxidatively modified mtDNA. 
 
Figure 3. Cytokine and chemokine secretion of primary human pDCs in response to native or 
oxidized mtDNA. ELISA was used to assess the concentration of released TNF- (A) and IL-
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8 (B) from primary human pDCs in response to a 24-h exposure to native or oxidatively 
modified mtDNA purified from untreated or antimycin A-treated HL-60 human cells. In 
parallel experiments, mtDNA was administered in combination with a specific TLR9 inhibitor 
(TTAGGG). Data are presented as means ± SE of three independent experiments. * p<0.05 vs. 
untreated cells; # p<0.05 vs. mtDNA- or ox-mtDNA-treated cells. Ox-mtDNA: oxidatively 
modified mtDNA. 
 
Figure 4. Type I IFN production from primary human pDCs in response to native or oxidized 
mtDNA. Freshly isolated primary human pDCs were treated with native or oxidatively 
modified mtDNA purified from untreated and oxidative stress-exposed HL-60 human cells 
alone or in complex with LL-37 protein in the absence or presence of TLR9 antagonist 
(TTAGGG). After a 24-h incubation the levels of IFN- in the supernatant of cells were 
determined by ELISA. Data are presented as means± SE of three individual experiments. *** 
p<0.001, **** p<0.0001 vs. untreated cells. Ox-mtDNA: oxidatively modified mtDNA, N/D: 
not determined.  
 
Figure 5. Phenotypic analysis of blood pDCs isolated from mice injected with native or 
oxidatively modified mtDNA. For in vivo stimulation of pDCs, 129Sv female mice were 
injected with sterile PBS as a control or native and oxidatively modified mtDNA preparations 
isolated from untreated cells or antimycin A-exposed murine SP2/0-Ag14 cells in complex 
with DOTAP cationic liposomal transfection reagent. Blood cells from mice were collected 6 
h after PBS or mtDNAs injection and stained as described in Materials and Methods. Mouse 
pDCs were gated as mPDCA-1+ cells and the expression of mouse CD86 (A) and I-A/I-E (B) 
was determined on the gated mPDCA-1+ pDC population. Relative fluorescence was 
calculated using the respective isotype-matched control for each monoclonal antibody. Data 
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are presented as means ± SE of 13 animals in four independent experiments. ** p<0.01, **** 
p<0.0001 vs. PBS-treated control mice. Ox-mtDNA: oxidatively modified mtDNA. 
 
Figure 6. Cytokine and chemokine levels in the sera of mice injected with native or oxidized 
mtDNA. Sera from 129Sv mice were collected at 6 h after injection with PBS (control), as 
well as native or oxidatively modified mtDNA extracted from untreated or antimycin A-
exposed murine SP2/0-Ag14 cells and then tested for IL-6 (A), TNF- (B), CXCL1/KC (C), 
and IFN- (D) proteins using specific ELISA kits. Data are presented as means ± SE of 17 
animals in four independent experiments. *** p<0.001, **** p<0.0001 vs. PBS-treated 
control mice. Ox-mtDNA: oxidatively modified mtDNA, N/D: not determined. 
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